《瑞銀窩輪》百威挑戰30港元 看好可留意高槓桿、低溢價購11277
大市週三的焦點繼續落在新股百威亞太(1876)身上，繼週一高見28.9港元水平後，股份週三發力，上試30港元水平，升超過半成。之前提及過，百威未上市已獲得國際指數公司青睞，富時羅素已明言將於百威完成上市後將此公司以「快速通道」加入全球股票指數，由於納入大型指數意味股份有機會得到基金公司跟隨作配置，對股份多起正面作用。而百威上市當日，已有券商發表報告看好。
跟百威同步上市的認股證週一交投活躍，投資者主要留意輕微價外選擇。而根據過往經驗，在股價上市一段時間後，引伸波幅或有回落空間，所以投資者在揀選百威認購證時，可留意引伸波幅水平較低的選擇，以減低該證波幅大幅度下行的風險。而過去兩日股價急升，不少投資者都開始留意較價外的選擇。如投資者看好百威，可留意百威亞太認購11277，行使價33.18港元，20年3月到期，有效槓桿約5.0倍。11277為熱門交投的百威認購證中，引伸波幅較低適宜作中線部署，而此證敏感度較高亦適合即市部署的人士。
更多窩輪牛熊資訊：瑞銀證網站: www.ubs.com/hkwarrants卓素華董事
瑞銀亞洲股票衍生產品銷售部
本產品並無抵押品。 如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。筆者為UBS AG的代表(作為證監會持牌人)，並未持有相關上市公司的任何財務權益。本資料由瑞銀刊發，其並不構成買賣建議、邀請、要約或遊說。結構性產品價格可急升或急跌，投資者可能會蒙受全盤損失。過往表現並不反映將來表現。牛熊證備強制贖回機制而可能被提早終止，屆時 (i) N類牛熊證投資者將不獲發任何金額;而(ii) R類牛熊證之剩餘價值可能為零。投資前應瞭解有關風險，並諮詢專業顧問及查閱有關上市文件。UBS Securities Hong Kong Limited為結構性產品之流通量提供者，亦可能是唯一報價者或巿場參與者。(C) UBS 2019。版權所有。~重要聲明:
以上資訊由第三方提供，AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告，不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料，本公司亦不負品質保證之責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
